NCT04254107 2025-02-10A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerSeagen Inc.Phase 1 Terminated133 enrolled
NCT02706392 2022-08-31Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesFred Hutchinson Cancer CenterPhase 1 Terminated21 enrolled 19 charts
NCT02576665 2020-02-07A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Tocagen Inc.Phase 1 Terminated21 enrolled